Form 4: Molina Healthcare Director Steven Orlando Reports Future Equity Grant

Molina Healthcare, Inc. Director Steven J. Orlando reported the future acquisition of 180 shares of common stock on July 1, 2025, as part of his director compensation plan.

Summary

• Steven J. Orlando, a Director of Molina Healthcare, Inc. (MOH), is scheduled to acquire 180 shares of common stock on July 1, 2025.
• This acquisition is a stock grant under the Issuer's 2025 Equity Incentive Plan, provided in connection with his services as a Director.
• The shares were granted at a price of $306.29 per share, which was the closing price of Molina Healthcare's common stock on July 1, 2025.
• The grant represents one quarter of the annual equity award for directors, valued at $55,000, from an aggregate annual award of $220,000.
• Following this transaction, Steven J. Orlando will beneficially own a total of 18,223 shares of common stock, comprising 16,723 shares held indirectly by the Orlando Family Trust and 1,500 shares held indirectly by his 401(k).

Sentiment

Score: 7

Explanation: The document reports a routine, pre-planned equity grant to a director, which is generally a positive sign of aligning interests and standard compensation practice. There are no negative financial implications or risks disclosed.

Positives

• Director Steven J. Orlando is receiving an equity grant, which aligns his financial interests with those of the company's shareholders.
• The grant is part of a structured 2025 Equity Incentive Plan, indicating a clear and pre-defined compensation strategy for directors.

Future Outlook

The filing indicates a planned future stock grant on July 1, 2025, as part of the company's ongoing 2025 Equity Incentive Plan for directors, suggesting a continued compensation structure.

Industry Context

This Form 4 filing reflects a standard practice of public companies compensating their directors with equity, aligning their interests with long-term shareholder value. Such grants are common across the healthcare industry and other sectors for non-employee directors.

Comparison to Industry Standards

• The grant of equity to directors is a common compensation practice in publicly traded companies, including those in the healthcare sector like Molina Healthcare.
• While specific compensation amounts vary by company size and industry, the structure of providing equity as part of director compensation is consistent with corporate governance best practices aimed at aligning director incentives with shareholder returns.
• Similar equity compensation plans are observed at peers like Centene Corporation (CNC) or Humana Inc. (HUM), where directors also receive stock awards as part of their annual remuneration, though the specific values and share counts would differ based on company market capitalization and compensation policies.

Corporate Governance

Stakeholder Impact

• Shareholders: The equity grant aligns the director's interests with shareholders, potentially encouraging long-term value creation.

Key Dates

Keywords

Molina Healthcare, MOH, Steven J. Orlando, Director Compensation, Stock Grant, Equity Incentive Plan, SEC Form 4, Insider Transaction, Beneficial Ownership